Abstract: The initial clozapine dose is 12.5 mg, increasing gradually to 300-400 mg/d, up to a licensed maximum of 900 mg/d. A plasma level of 350 μg/L should be aimed for to ensure an adequate trial, but response may occur at lower plasma level, depending on many factors including augmentation and Ethnicity, here we present the case of a 24-year-old Saudi male with refractory schizophrenia who responded to low dose of clozapine and lamotrigine augmentation.
Keywords: clozapine; lamotrigine; Treatment Resistance Schizophrenia.
Title: Low Dose Clozapine with Lamotrigine Augmentation in Treatment Resistance Schizophrenia: A Case Report
Author: Alkhamees Abdulmajeed
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
